Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Cancer Trials Ireland
Cohort A will consist of 100 CRAC patients with stage II/III resectable disease due for adjuvant chemotherapy.
Cohort B will consist of 30 patients with stage II resectable disease for observation only.
Both cohorts will have a follow up period of up to 2 years, post chemotherapy for cohort A and post resection for cohort B.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patient must be able to give written informed consent
Histologically or cytologically confirmed CRAC
Cohort A: colorectal cancer patients with stage II/III resectable disease due for adjuvant chemotherapy OR Cohort B: colorectal cancer patients with stage II resectable disease for observation only
Age ≥ 18 years
Treatment with curative intent
Eastern Cooperative Oncology Group (ECOG) Performance status 0 - 2
You may not be if
Presence of a medical or psychiatric condition, which, in the opinion of the investigator, would potentially pose a risk to the patient when participating in this trial
Evidence of a metastatic disease
Clareo Health | Plasma Biomarkers C-RAC, ICORG 12-27, V1
